A 2 year-old Leigh syndrome patient homozygous for the known pathogenic c.355G > C (pAsp119His) mutation in NDUFS4 responded strikingly well to mTOR inhibition therapy, with a reversal of brain lesions and striking recovery of gross motor function which persisted through ~ 20 months of therapy. The gene discussed is NDUFS4; the disease is Leigh syndrome.